Competition office fines pharmas for misleading customers
Hungary's Competition Office (GVH) has announced on Thursday it had fined pharma company Pannon Medisana Kft Ft 1.5 million for unfair manipulation of consumer choice.
It also imposed a Ft 300,000 fine on L'Orelle Bt. “In the competition supervision proceedings the Competition Council of the GVH concluded that Pannon Medisana Kft.'s advertisements were capable of misleading consumers because it attributed healing effects to its "Medinose" product, although it could not prove the truthfulness of this statement," the GVH said in a statement.
“In the competition supervision proceedings the Competition Council of the GVH concluded that L'Orelle Bt.'s advertisements on its website as well as in a magazine were capable of misleading consumers because it attributed healing effects to its "rhinoBeam" product, although it could not prove the truthfulness of this statement. Also, it was deemed to be misleading that L'Orelle Bt. published, in the framework of a promotion, the "previous" price of the same product, although it has not applied this price previously," the GVH said in a separate statement. (portfolilo.hu)
SUPPORT THE BUDAPEST BUSINESS JOURNAL
Newspaper organizations across the globe have struggled to find a business model that allows them to continue to excel, without compromising their ability to perform. Most recently, some have experimented with the idea of involving their most important stakeholders, their readers.
We would like to offer that same opportunity to our readers. We would like to invite you to help us deliver the quality business journalism you require. Hit our Support the BBJ button and you can choose the how much and how often you send us your contributions.